Heptares, Cubist in GPCR discovery deal

Heptares Therapeutics Ltd. (Welwyn Garden City, U.K.) and Cubist Pharmaceuticals Inc. (NASDAQ:CBST) partnered to discover and develop compounds against two undisclosed GPCR targets selected by Cubist....